Viewing Study NCT06952803


Ignite Creation Date: 2025-12-24 @ 7:32 PM
Ignite Modification Date: 2025-12-30 @ 6:42 AM
Study NCT ID: NCT06952803
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-04-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module